Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Among the high prevalence of cerebrovascular diseases nowadays, acute ischemic stroke
stands out, representing a significant worldwide health issue with important socio-economic …

Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Background and Purpose—The authors present an overview of the current evidence and
management recommendations for evaluation and treatment of adults with acute ischemic …

Background Magnesium sulfate is neuroprotective in preclinical models of stroke and has
shown signals of potential efficacy with an acceptable safety profile when delivered early …

Objectives: Efficacy of thrombolytic therapy for ischemic stroke decreases with time elapsed
from symptom onset. We analyzed the effect of interventions aimed to reduce treatment …

Background High blood pressure is common in acute stroke and is a predictor of poor
outcome; however, large trials of lowering blood pressure have given variable results, and …

Thrombolysis with alteplase administered within a narrow therapeutic window provides an
effective therapy for acute ischaemic stroke. However, mainly because of prehospital delay …

The Get With The Guidelines-Stroke program which, began 20 years ago, is one of the
largest and most important nationally representative disease registries in the United States …

Stroke is the third cause of death worldwide and the main cause of chronic, severe adult
disability. We focus on acute ischaemic stroke, which accounts for approximately 80% of all …